Vaginal Atrophy

71 registered clinical trials studyying Vaginal Atrophy — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women NCT07526948	Albert Einstein College of Medicine	Phase 4
Not Yet Recruiting	Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial NCT05379153	Alliance for Clinical Trials in Oncology	Phase 3
Not Yet Recruiting	Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause NCT05483634	Mackay Memorial Hospital	—
Recruiting	ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy NCT07346287	Stratpharma AG	Phase 4
Not Yet Recruiting	Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women NCT06564883	Biolab Sanus Farmaceutica	Phase 3
Recruiting	Postpartum Vaginal Estrogen for Breastfeeding Patients NCT05457972	University Hospitals Cleveland Medical Center	Phase 4
Not Yet Recruiting	The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy NCT06514586	Oxagon	Phase 3
Completed	Perceived Effectiveness of the Vaginal Moisturizer Investigational Product Under Normal Conditions of Use. NCT06353945	Herbarium Laboratorio Botanico Ltda	N/A
Active Not Recruiting	Effect of Local Estriol Treatment Before Vaginal Repair Surgery NCT06391372	Hatice Tukenmez Kurnaz	Phase 3
Active Not Recruiting	PRP Injections for Genitourinary Syndrome of Menopause NCT06028009	Medstar Health Research Institute	N/A
Recruiting	VALOR: Vaginal Atrophy & Long-term Observation of Recovery NCT05953090	Stratpharma AG	N/A
Completed	Elastographic Improvement of Vaginal Atrophy Treated by Erbium Yag Laser NCT06000202	Istanbul University - Cerrahpasa	N/A
Completed	Clinical Performance and Safety of the VITA AV Clinical System NCT06207227	AVeta Medical	N/A
Terminated	Vaginal Estradiol Use in Pessary Care NCT05458375	University of South Florida	EARLY_Phase 1
Terminated	Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman NCT05627791	Department of Medical Services Ministry of Public Health of Thailand	Phase 2 / Phase 3
Withdrawn	Laser Treatment of Genito-urinary Syndrome in Women NCT03238053	Herning Hospital	N/A
Completed	Low-level Laser Therapy for Genitourinary Syndromes and Stress Urinary Incontinence NCT06136975	National Taiwan University Hospital	—
Recruiting	Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of V NCT07024667	Hillel Yaffe Medical Center	N/A
Completed	Clinical Trial of "Magic Gyno" Laser Device NCT05463081	MeLSyTech, Ltd	N/A
Recruiting	Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser NCT05335317	MeLSyTech, Ltd	N/A
Completed	Real-world Evidence Study on the Performance and Safety of Halova Ovules NCT05654610	Perfect Care Distribution	—
Completed	Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Sufferin NCT05211505	Dr. August Wolff GmbH & Co. KG Arzneimittel	Phase 4
Completed	Vulvovaginal Atrophy Correction Using Neodymium Laser NCT04735549	MeLSyTech, Ltd	N/A
Completed	Clinical Evaluation of Fractional Bi-Polar Radio-Frequency for Symptoms of Vulvovaginal Atrophy NCT05398172	InMode MD Ltd.	N/A
Terminated	Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors NCT04493333	University of Arkansas	Phase 2
Withdrawn	A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal At NCT04159493	Aspen USA Inc	Phase 2
Completed	Non-Interventional Multicentre Post-market Study of Ectoin® Vaginal Gel for Symptomatic Treatment of Vaginal A NCT04910906	Bitop AG	—
Recruiting	Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo NCT04807894	Maimonides Medical Center	Phase 4
Completed	Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial NCT04079218	Kerry Murphy	Phase 4
Completed	Histological Modifications of Postmenopausal Vaginal Mucosa After Repeated Carbon Dioxide (CO2) Laser Treatmen NCT04868812	IRCCS San Raffaele	N/A
Completed	Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of t NCT04659668	Mesoestetic Pharma Group S.L.	N/A
Active Not Recruiting	LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPM NCT04081805	Federal University of São Paulo	N/A
Completed	Clinical Study to Compare the Efficacy of Erbium-Yag Laser or CO2RE Intimate Laser With Sham (COER) NCT04039555	Instituto Palacios	N/A
Completed	A Clinical Clinical Observation of CO2 Fractional Laser in Female Vaginal Repair NCT04492176	Xijing Hospital	N/A
Completed	Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy NCT03996603	University of Alabama at Birmingham	Phase 4
Completed	Evaluation of VagiVital® for Treatment of Vaginal Atrophy NCT03998722	PepTonic Medical AB	N/A
Unknown	Effect of Hybrid Laser 10600+1540 nm on GSM NCT03956563	Quanta System, S.p.A.	N/A
Unknown	Effect of Laser Therapy on Vaginal Tissue NCT05898191	Institute for the Care of Mother and Child, Prague, Czech Republic	N/A
Unknown	Vaginal Laser Therapy in Breast Cancer Survivors NCT03738605	National and Kapodistrian University of Athens	N/A
Completed	Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal W NCT03770065	Viramal Limited	—
Completed	Comparative Study: Vaginal Promestriene Use, Fractional CO2 LASER and Radiofrequency in the Vaginal Atrophy Tr NCT04717245	University of Sao Paulo General Hospital	N/A
Completed	Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function NCT03493126	Ohio State University	Phase 4
Suspended	A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes NCT03547089	W. Grant Stevens, MD	N/A
Completed	Radiofrequency and Hybrid Fractional Laser for Vaginal Rejuvenation NCT03316950	University of Texas Southwestern Medical Center	N/A
Completed	CO2 Laser in the Treatment of the GSM - (Genitourinary Syndrome of Menopause) Genitourinary Syndrome of Menopa NCT03939078	Universidade Federal Fluminense	—
Unknown	Evaluation of Efficacy and Safety of Votiva for Vaginal Rejuvenation NCT03520426	Walden, Jennifer L., M.D.,P.L.L.C.	N/A
Unknown	Vaginal CO2 Laser and the Genitourinary Syndrome of Menopause NCT03754205	National and Kapodistrian University of Athens	N/A
Completed	Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus NCT03063684	Hadassah Medical Organization	N/A
Completed	Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause NCT03178825	Sciton	N/A
Completed	Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, NCT02967510	ITF Research Pharma, S.L.U.	Phase 2
Completed	Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes NCT02937805	Petra Larmo	N/A
Completed	Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (Fem NCT02747641	Alma Lasers Inc.	N/A
Completed	A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopaus NCT02413008	ITF Research Pharma, S.L.U.	Phase 2
Unknown	Evaluate the Efficacy, Safety and Tolerability of a Non-hormonal Intravaginal Gel in Postmenopausal Women With NCT02571127	Farmoquimica S.A.	Phase 4
Unknown	Clinical Study of the CO2RE Laser Device Performance for Vaginal Atrophy Treatments NCT02704741	Syneron Medical	N/A
Completed	Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause NCT02013544	EndoCeutics Inc.	Phase 3
Completed	A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin NCT01975129	PepTonic Medical AB	Phase 2
Terminated	Efficacy and Safety Of Spil's Estradiol Vaginal Tablet NCT01753102	Sun Pharmaceutical Industries Limited	Phase 3
Unknown	VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women NCT00453089	Bionovo	Phase 1 / Phase 2
Completed	Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women NCT01987804	PepTonic Medical AB	Phase 2
Completed	Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy NCT01358760	EndoCeutics Inc.	Phase 3
Completed	DHEA Against Vaginal Atrophy - Safety Study of 12 Months NCT01256671	EndoCeutics Inc.	Phase 3
Completed	DHEA Against Vaginal Atrophy - 3-Month Efficacy Study NCT01256684	EndoCeutics Inc.	Phase 3
Completed	Vaginal Inflammation Markers in Postmenopausal Women With and Without Symptoms of Vaginal Inflammation NCT01899612	Insel Gruppe AG, University Hospital Bern	—
Completed	Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women NCT01432470	PepTonic Medical AB	Phase 2
Completed	The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse NCT00803335	TriHealth Inc.	Phase 3
Completed	Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy NCT04574999	Italfarmaco S.A	Phase 3
Completed	Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients NCT00607295	Seoul National University Hospital	Phase 3
Completed	Topical DHEA Against Vaginal Atrophy NCT01846442	EndoCeutics Inc.	Phase 3
Completed	DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal A NCT00429806	CHU de Quebec-Universite Laval	Phase 1
Completed	Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause NCT00238732	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3